Schedule 13G ownership disclosure

Idera Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 45168K405

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,663,577
Percent of class
16.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-043821
Form type
SC 13G
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Sep 06, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub